NIH-funded research R01 grant

Understanding the sexual cycle of Pneumocystis to find new treatments for HIV-related pneumonia

Official title: Elucidating the Sexual Cycle of HIV/AIDS-Related Pneumocystis Pneumonia

Funded at University of Cincinnati · NIH-11380769 · Data updated 2026-11-12

A research project at the University of Cincinnati is exploring how Pneumocystis jirovecii completes its life cycle to identify new drug targets for Pneumocystis pneumonia in people with HIV/AIDS.

More AIDS research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 1, 2025
Project endMay 31, 2029
Funding year2026
Award (this year)$468,042
NIH project number5R01HL176858-02
Project IDNIH-11380769 on NIH RePORTER

Who could benefit from this research

Could help

People with HIV/AIDS or other conditions that weaken the immune system who are at risk for Pneumocystis pneumonia.

Less likely to help

Patients without Pneumocystis pneumonia or those not involved in antifungal treatment development may not directly benefit.

What this research studies

This project studies the sexual reproduction process of Pneumocystis jirovecii, a fungus that causes dangerous pneumonia in people with weakened immune systems. Scientists will map when and how the organism undergoes sexual development and how that helps it survive and spread. They will test how antifungal drugs that block this reproductive cycle affect the infection in animal models and analyze gene expression changes to pinpoint potential new drug targets. The goal is to discover strategies that could reduce transmission and improve treatment when current options are limited by drug intolerance or toxicity.

Why it matters

Potential benefit: If successful, the work could lead to new treatments that target the sexual cycle of Pneumocystis, potentially improving outcomes for patients with HIV/AIDS who develop Pneumocystis pneumonia.

How similar studies have gone: Previous studies in mice suggest that targeting the sexual cycle can eradicate Pneumocystis pneumonia, supporting this approach as promising but still under investigation.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Smulian, Alan George — University of Cincinnati
  • Study coordinator: Smulian, Alan George

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.